Phospho-EZR (Tyr478) Antibody

What is Phospho-EZR (Tyr478) Antibody and what is its specificity?

Phospho-EZR (Tyr478) Antibody is a polyclonal antibody specifically designed to detect ezrin only when phosphorylated at tyrosine residue 478. This antibody recognizes the peptide sequence around the phosphorylation site of tyrosine 478 (P-V-Y(p)-E-P) derived from human ezrin . The specificity is ensured through a rigorous purification process involving affinity-chromatography using epitope-specific phosphopeptide, with non-phospho specific antibodies removed through chromatography using non-phosphopeptide . This high specificity allows researchers to distinguish between phosphorylated and non-phosphorylated forms of ezrin, enabling detailed investigations of phosphorylation-dependent functions.

What applications is Phospho-EZR (Tyr478) Antibody validated for?

The antibody has been validated for multiple applications:

The optimal dilutions should be determined by individual researchers based on their specific experimental conditions and sample types .

What are the recommended storage and handling conditions?

For optimal performance and stability:

• Store at -20°C or -80°C

• Avoid repeated freeze-thaw cycles to prevent degradation

• The antibody is typically provided in phosphate buffered saline (pH 7.4) containing 150mM NaCl, 0.02% sodium azide, and 50% glycerol as a stabilizer

• Long-term stability is approximately one year when stored properly

How does phosphorylation at Tyr478 differ functionally from other ezrin phosphorylation sites?

Ezrin phosphorylation occurs at multiple sites, with Tyr478 and Thr567 being the most extensively studied. The functional differences between these phosphorylation sites reveal distinct regulatory mechanisms:

• Thr567 phosphorylation: Primarily breaks the N-C intramolecular binding of ezrin, transitioning it to an active conformation that enhances F-actin binding and strengthens membrane interaction . This phosphorylation site is critical for ezrin activation and is associated with microvilli formation and membrane ruffling .

• Tyr478 phosphorylation: While less extensively characterized than Thr567, Tyr478 phosphorylation appears to regulate different aspects of ezrin function. The tyrosine phosphorylation may affect protein-protein interactions distinct from those regulated by threonine phosphorylation, potentially influencing signaling pathway specificity .

Research by comparative phosphorylation studies suggests that these different phosphorylation events may work in concert but regulate distinct aspects of ezrin's function in cell adhesion, migration, and cytoskeletal organization .

What experimental factors affect ezrin phosphorylation status?

Several experimental conditions can significantly impact ezrin phosphorylation levels:

• Phosphatase inhibitors: Treatment with Calyculin-A (CLA) dramatically increases phosphorylation levels of ezrin

• Kinase inhibitors: Staurosporine treatment decreases phosphorylation of ezrin, with dose-dependent effects

• Metabolic inhibitors: Sodium azide treatment reduces ATP levels and consequently decreases phosphorylation

• Cell adhesion status:

  • Detached cells show increased ezrin phosphorylation

  • Adherent cells display lower phosphorylation levels, particularly at Thr567

  • Reattachment induces dephosphorylation

• Tissue-specific variation: High levels of Thr567 phosphorylation are found in brush border membranes of renal proximal tubule cells and small intestine enterocytes, compared to lower levels in gastric parietal cells

These factors must be carefully controlled in experimental design to accurately assess phosphorylation status.

How can researchers validate antibody specificity for phosphorylated ezrin?

Rigorous validation of Phospho-EZR (Tyr478) Antibody specificity is essential for experimental reliability:

• Peptide competition assay: Compare antibody binding in the presence of phosphorylated versus non-phosphorylated peptides corresponding to the Tyr478 region

• Phosphatase treatment controls: Treat one sample with lambda phosphatase to remove phosphorylation and compare with untreated sample

• Kinase manipulation: Compare samples from cells treated with tyrosine kinase inhibitors versus activators

• Genetic approaches: Use cells expressing phospho-deficient mutants (Y478F) as negative controls

• Multiple antibody comparison: Validate findings using alternative antibodies targeting the same phosphorylation site from different manufacturers

The purification method described in product documentation confirms that non-phospho specific antibodies were removed by chromatography using non-phosphopeptide , providing a baseline level of specificity.

What are the key positive and negative controls for phosphorylation experiments?

Comparative controls between tissues are also informative, as renal proximal tubules show higher basal phosphorylation levels than gastric parietal cells .

What is the optimal protocol for western blot detection of Phospho-EZR (Tyr478)?

For optimal western blot detection of phosphorylated ezrin at Tyr478:

• Sample preparation:

  • Harvest cells directly into boiling SDS-loading buffer to immediately inactivate phosphatases

  • Alternatively, use lysis buffer containing phosphatase inhibitors (e.g., 1 μM Calyculin-A, 10 mM sodium fluoride, 1 mM sodium orthovanadate)

  • Keep samples on ice during preparation

• Gel electrophoresis and transfer:

  • Use 8-10% SDS-PAGE gels (ezrin has a molecular weight of ~69-80 kDa)

  • Transfer to PVDF or nitrocellulose membrane using standard protocols

• Antibody incubation:

  • Block membrane in 3-5% BSA (preferred over milk for phospho-epitopes)

  • Dilute primary antibody 1:500-1:1000 in blocking buffer

  • Incubate overnight at 4°C for optimal signal-to-noise ratio

  • Use HRP-conjugated secondary antibody at manufacturer's recommended dilution

• Detection and analysis:

  • Develop using ECL detection system

  • Expected band size is 69-80 kDa

  • Always include total ezrin antibody detection on the same samples for normalization

This protocol is adaptable based on specific experimental requirements and should be optimized for each laboratory's conditions.

How can researchers troubleshoot weak or inconsistent phospho-ezrin signals?

When facing challenges with phospho-ezrin detection:

• Phosphorylation preservation issues:

  • Ensure phosphatase inhibitors are fresh and active

  • Process samples quickly and at cold temperatures

  • Consider direct lysis in boiling SDS-buffer for immediate phosphatase inactivation

• Antibody-related issues:

  • Titrate antibody concentration (try higher concentrations)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Test alternative blocking agents (BSA vs. milk)

  • Consider using enhanced detection systems

• Sample preparation problems:

  • Maximize phosphorylation levels by treating samples with phosphatase inhibitors

  • Ensure adequate protein loading (50-100 μg total protein)

  • Verify phosphorylation status using alternative phospho-sites as positive controls

• Technical considerations:

  • Check transfer efficiency with reversible staining

  • Reduce washing stringency

  • Ensure antibody lot consistency between experiments

• Biological variability:

  • Control for cell confluency and passage number

  • Standardize cell treatment conditions

  • Consider tissue-specific phosphorylation differences

What techniques can distinguish between different ezrin phosphorylation states?

Multiple complementary approaches can differentiate ezrin phosphorylation states:

• Site-specific phospho-antibodies: Use antibodies targeting different phosphorylation sites (Tyr478, Thr567, Thr566) to create a phosphorylation profile

• Phospho-mimetic and phospho-deficient mutants: Compare wild-type ezrin with T567D (phospho-mimetic) or Y478F (phospho-deficient) mutants

• Detergent extraction analysis: Triton X-100 extraction differentiates between cytoskeleton-associated (phosphorylated) and soluble (non-phosphorylated) ezrin fractions

• Mass spectrometry: For comprehensive phosphorylation site mapping and quantification across multiple sites simultaneously

• Subcellular localization studies: Phosphorylated ezrin typically localizes to plasma membrane and microvillar structures

Each approach provides distinct and complementary information about ezrin's phosphorylation status and functional state.

How can phosphorylation status be preserved during sample preparation?

Preserving phosphorylation during sample preparation requires multiple strategies:

• Immediate inactivation:

  • Direct lysis in boiling SDS-loading buffer for rapid phosphatase inactivation

  • Flash-freezing samples in liquid nitrogen prior to processing

• Chemical inhibition:

  • Use phosphatase inhibitor cocktails in all buffers

  • Include specific inhibitors: 1 μM Calyculin-A for serine/threonine phosphatases

  • Add tyrosine phosphatase inhibitors (1 mM sodium orthovanadate)

  • Include protease inhibitors to prevent degradation

• Physical conditions:

  • Maintain samples at 4°C throughout preparation

  • Minimize processing time

  • Avoid excessive mechanical disruption

• Storage considerations:

  • Store samples at -80°C rather than -20°C for long-term storage

  • Avoid repeated freeze-thaw cycles

For time course studies examining phosphorylation dynamics, samples should be collected and immediately boiled in SDS-loading buffer as demonstrated in several published protocols .

How does ezrin phosphorylation regulate cell morphology and adhesion?

Ezrin phosphorylation plays a critical role in regulating cell shape and adhesion properties:

• Cell morphology regulation:

  • Increased phosphorylation (particularly at Thr567) induces cell rounding and formation of spherical cell shape

  • Expression of phospho-mimetic ezrin mutants (T567D) causes aberrant growth of membrane projections

  • Phosphorylated ezrin increases cell surface rigidity, making cells more resistant to deformation

• Cell adhesion dynamics:

  • Higher levels of phosphorylated ezrin inhibit cell adhesion to substrates

  • Dephosphorylation of ezrin is essential for cell attachment and spreading

  • During cell adhesion, ezrin phosphorylation follows a sequential pattern:

    1. Initial cell-substrate contact

    2. Localized ezrin dephosphorylation

    3. Cell shape changes from spherical to spread

    4. Development of firm attachment

• Microvilli formation:

  • Phosphorylation turnover empowers ezrin to reposition membrane along filamentous actin

  • Higher phosphorylation levels are required for dense and uniform distribution of microvilli at brush border surfaces

  • Ezrin phosphorylation enhances its association with F-actin while maintaining membrane interaction

These regulatory mechanisms establish ezrin as a key mediator of cellular surface plasticity and morphological adaptation.

How does ezrin phosphorylation vary across different tissues and cell types?

Significant tissue-specific differences exist in ezrin phosphorylation patterns:

These differences reflect the specialized functions of ezrin in different cellular contexts. In brush border-rich tissues, higher steady-state phosphorylation supports the dense microvillar structures, while in gastric parietal cells, the dynamics of phosphorylation appear more important for membrane remodeling .

What are the molecular mechanisms regulating ezrin phosphorylation turnover?

Ezrin phosphorylation involves a dynamic balance between kinase-mediated phosphorylation and phosphatase-mediated dephosphorylation:

• Kinase regulation:

  • Multiple kinases can phosphorylate ezrin at different sites

  • Tyrosine kinases target Tyr478 and other tyrosine residues

  • PKC family members and Rho-kinase can phosphorylate Thr567

  • Broad-spectrum kinase inhibitors like staurosporine decrease ezrin phosphorylation

• Phosphatase activity:

  • Protein phosphatases continuously dephosphorylate ezrin

  • Phosphatase inhibition with Calyculin-A dramatically increases phosphorylation levels

  • The balance between kinase and phosphatase activities determines the steady-state phosphorylation level

• Turnover dynamics:

  • High turnover of ezrin phosphorylation occurs in all epithelia studied

  • Phosphorylation turnover empowers ezrin to relax and reposition membrane relative to the underlying cytoskeleton

  • This dynamic process enables surface plasticity during filament growth or membrane remodeling

• Structural basis:

  • Phosphorylation of Thr567 breaks intramolecular N-C binding in ezrin

  • This conformational change activates ezrin, allowing F-actin binding and enhanced membrane interaction

  • FRET analysis has visualized these conformational changes in situ

The continuous phosphorylation-dephosphorylation cycle appears essential for ezrin's role in dynamic membrane-cytoskeleton interactions.

What experimental approaches can manipulate ezrin phosphorylation levels for functional studies?

Researchers can modulate ezrin phosphorylation using several experimental strategies:

• Pharmacological approaches:

  • Phosphatase inhibitors (Calyculin-A, 1 μM) to increase phosphorylation

  • Broad-spectrum kinase inhibitors (Staurosporine, 1 μM) to decrease phosphorylation

  • Metabolic inhibitors (sodium azide, 10 mM) to reduce ATP levels and decrease phosphorylation

  • Growth factor treatments (EGF) to stimulate specific signaling pathways leading to ezrin phosphorylation

• Genetic approaches:

  • Expression of phospho-mimetic mutants (T567D) to simulate constitutive phosphorylation

  • Expression of phospho-deficient mutants (T567A or Y478F) to prevent phosphorylation

  • siRNA knockdown of specific kinases or phosphatases

  • CRISPR/Cas9-mediated gene editing to create phospho-site mutants in endogenous ezrin

• Cell adhesion manipulation:

  • Cell detachment by trypsinization increases ezrin phosphorylation

  • Replating cells on different substrates can modulate phosphorylation dynamics

• Triton X-100 extraction analysis:

  • Differential extraction to separate cytoskeleton-associated (phosphorylated) ezrin from soluble forms

  • Can be combined with other treatments to assess changes in ezrin-cytoskeleton association

These approaches allow researchers to investigate the functional consequences of altered ezrin phosphorylation in various cellular processes.